Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern?

被引：17
|
作者：
Chatterjee, Srijan [1 ]
Bhattacharya, Manojit [2 ]
Dhama, Kuldeep [3 ]
Lee, Sang-Soo [1 ]
Chakraborty, Chiranjib [4 ]
机构：
[1] Hallym Univ, Chuncheon Sacred Heart Hosp, Inst Skeletal Aging & Orthopaed Surg, Chuncheon Si 24252, Gangwon Do, South Korea
[2] Fakir Mohan Univ, Dept Zool, Balasore 756020, Odisha, India
[3] Indian Vet Res Inst, Div Pathol, ICAR, Bareilly 243122, Uttar Pradesh, India
[4] Adamas Univ, Sch Life Sci & Biotechnol, Dept Biotechnol, Kolkata 700126, W Bengal, India
来源：
MOLECULAR THERAPY-NUCLEIC ACIDS | 2023年 / 32卷
关键词：
RECEPTOR-BINDING DOMAIN; PROTEASE; DRUG;
D O I：
10.1016/j.omtn.2023.03.013
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：263 / 266
页数：4
相关论文
共 50 条
  • [1] The Rising Concern of the SARS-CoV-2 Omicron Subvariants and Their Hybrids
    Ahmed, H. Shafeeq
    INDIAN JOURNAL OF RESPIRATORY CARE, 2022, 11 (03) : 283 - 284
  • [2] An Investigation of Nirmatrelvir (Paxlovid) Resistance in SARS-CoV-2 Mpro
    Yaghi, Rasha M.
    Wylie, Dennis C.
    Andrews, Collin L.
    Dickert, Olivia H.
    Ram, Anjana
    Iverson, Brent L.
    ACS BIO & MED CHEM AU, 2024, 4 (06): : 280 - 290
  • [3] Reproduction numbers of SARS-CoV-2 Omicron subvariants
    Wang, Shuqi
    Zhang, Fengdi
    Wang, Zhen
    Du, Zhanwei
    Gao, Chao
    JOURNAL OF TRAVEL MEDICINE, 2022, 29 (08)
  • [4] Immune Evasion of SARS-CoV-2 Omicron Subvariants
    Ke, Hanzhong
    Chang, Matthew R.
    Marasco, Wayne A.
    VACCINES, 2022, 10 (09)
  • [5] SARS-CoV-2 Nirmatrelvir Resistance-A Concern for Immunocompromised Populations?
    Zhou, Zhuo
    Hong, Peng
    JAMA NETWORK OPEN, 2024, 7 (09)
  • [6] Reinfections with Different SARS-CoV-2 Omicron Subvariants, France
    Nguyen, Nhu Ngoc
    Houhamdi, Linda
    Delorme, Lea
    Colson, Philippe
    Gautret, Philippe
    EMERGING INFECTIOUS DISEASES, 2022, 28 (11) : 2341 - 2343
  • [7] Severity of SARS-CoV-2 Omicron XBB subvariants in Singapore
    Pung, Rachael
    Kong, Xin Peng
    Cui, Lin
    Chae, Sae-Rom
    Chen, Mark I-Cheng
    Lee, Vernon J.
    Ho, Zheng Jie Marc
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2023, 37
  • [8] Substitutions in SARS-CoV-2 Mpro Selected by Protease Inhibitor Boceprevir Confer Resistance to Nirmatrelvir
    Gammeltoft, Karen Anbro
    Zhou, Yuyong
    Ryberg, Line Abildgaard
    Pham, Long V.
    Binderup, Alekxander
    Hernandez, Carlos Rene Duarte
    Offersgaard, Anna
    Fahnoe, Ulrik
    Peters, Gunther Herbert Johannes
    Ramirez, Santseharay
    Bukh, Jens
    Gottwein, Judith Margarete
    VIRUSES-BASEL, 2023, 15 (09):
  • [9] Nirmatrelvir and molnupiravir maintain potent in vitro and in vivo antiviral activity against circulating SARS-CoV-2 omicron subvariants
    Rosales, Romel
    McGovern, Briana L.
    Rodriguez, M. Luis
    Leiva-Rebollo, Rocio
    Diaz-Tapia, Randy
    Benjamin, Jared
    Rai, Devendra K.
    Cardin, Rhonda D.
    Anderson, Annaliesa S.
    Sordillo, Emilia Mia
    van Bakel, Harm
    Simon, Viviana
    Garcia-Sastre, Adolfo
    White, Kris M.
    ANTIVIRAL RESEARCH, 2024, 230
  • [10] Evolutionary characteristics of SARS-CoV-2 Omicron subvariants adapted to the host
    Haijun Tang
    Yun Shao
    Yi Huang
    Shigang Qiao
    Jianzhong An
    Ruhong Yan
    Xin Zhao
    Fang Meng
    Xiaohong Du
    F. Xiao-Feng Qin
    Signal Transduction and Targeted Therapy, 8
12345